Transapical valve-in-valve implantation for regurgitant stented aortic bioprostheses.
Transcatheter aortic valve implantation (TAVI) is rapidly evolving as an alternative treatment option for elderly patients with severe symptomatic aortic stenosis and excessive risk for surgical intervention. Transcatheter valve-in-valve implantation is an alternative approach to redo-surgery for patients with degeneration of a bioprosthetic valve. Herein are reported three cases of successful transcatheter aortic valve-in-valve implantation for severely regurgitant bioprosthetic valves with a clinical follow up of more than 12 months.
Department of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland.
Peter
P
Wenaweser
Thomas
T
Pilgrim
Stephan
S
Windecker
Stefan
S
Stortecky
Thierry
T
Carrel
Alexander
A
Kadner
D000367:Age Factors; D000369:Aged, 80 and over; D001021:Aortic Valve / Q000503:physiopathology / Q000601:surgery*; D001022:Aortic Valve Insufficiency / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis / Q000009:adverse effects*; D006328:Cardiac Catheterization / Q000379:methods; D004452:Echocardiography; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D008297:Male; D019990:Perioperative Care / Q000379:methods; D012086:Reoperation / Q000379:methods; D016896:Treatment Outcome